On December 12, 2016, the 14th of 18 participants was treated in our ongoing study of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness in Marin, Calif. On January 6, 2017, the 16th participant was officially enrolled in the study. Led by Principal Investigator Phil Wolfson, M.D., with Co-Therapist Julane Andries, L.M.F.T., this study is gathering preliminary data about the safety and efficacy of MDMA-assisted psychotherapy for anxiety associated with diagnosis of a life-threatening illness in 18 participants. We are currently screening additional participants for this study. Learn more…
